View current press releases, to submit a press release please contact [email protected] for pricing.
NORTH CHICAGO, Ill., Oct. 2, 2023 /PRNewswire/ — AbbVie today announced new data on the investigational use of risankizumab (SKYRIZI®) in Crohn’s disease, upadacitinib (RINVOQ®) in ulcerative colitis and HUMIRA® (adalimumab) in inflammatory bowel disease (IBD) will be presented as live presentations…
DENVER and VANCOUVER, British Columbia, Oct. 01, 2023 (GLOBE NEWSWIRE) — SPOTLITE360 IOT SOLUTIONS, INC. (“SpotLite360” or the “Company”) (CSE: LITE) (OTC: SPLTF) (Frankfurt: 87A) announces that it has granted, effective after market close on September 30, 2023, an aggregate…
GROUPE IRDSociété anonyme au capital de 44 274 913,25 €Siège social : 40, rue Eugène Jacquet 59700 MARCQ-EN-BAROEUL RCS Lille Métropole 456 504 877 Euronext Paris – Compartiment C Code Isin FR 0000124232 COMMUNIQUE RAPPORT FINANCIER SEMESTRIEL La société annonce avoir, ce…
MADRI, 20 de setembro de 2023 /PRNewswire/ — O CaixaBank trabalhou em conjunto com a Revelock, recentemente adquirida pela Feedzai, para desenvolver uma solução baseada em Inteligência Artificial que tem o objetivo de prevenir fraudes nos canais bancários digitais. A…
CAMBRIDGE, Mass., Oct. 01, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that…
Proactis SA – Chiffre d’Affaires sur 12 mois au 31/07/2021 Paris – 30 Septembre 2021 – Proactis SA (Euronext: PROAC), leader dans la gestion globale du spend et des solutions collaboratives des processus business, diffuse aujourd’hui l’information financière concernant les…
RARITAN, N.J., Oct. 2, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that its investigational respiratory syncytial virus (RSV) vaccine candidate was highly effective in protecting against lower respiratory tract disease (LRTD) caused by RSV, demonstrating…
BOSTON, Oct. 01, 2023 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and military use, today…
Proactis SA Announces Financial Information for the year ended 31 July 2021 Paris – September 30, 2021 – Proactis SA (Euronext: PROAC), a leading provider of comprehensive spend management and business process collaboration solutions, today announces financial information for the…
SAN DIEGO, Oct. 2, 2023 /PRNewswire/ — Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Summit Therapeutics Inc. (“Summit” or the “Company”) (NASDAQ: SMMT). On September 21, 2023, Summit disclosed in…
